AngioDynamics Files 8-K on Financials
Ticker: ANGO · Form: 8-K · Filed: Jul 15, 2025 · CIK: 1275187
| Field | Detail |
|---|---|
| Company | Angiodynamics Inc (ANGO) |
| Form Type | 8-K |
| Filed Date | Jul 15, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, operations
TL;DR
AngioDynamics dropped an 8-K on July 15th covering financials and operations.
AI Summary
On July 15, 2025, AngioDynamics, Inc. filed an 8-K report detailing results of operations and financial condition. The filing also included Regulation FD disclosures and financial statements and exhibits. The company is incorporated in Delaware and headquartered in Latham, New York.
Why It Matters
This 8-K filing provides crucial updates on AngioDynamics' financial performance and operational results, which can impact investor decisions and market perception.
Risk Assessment
Risk Level: low — This filing is a standard 8-K reporting routine financial and operational information, not indicating any unusual or high-risk events.
Key Players & Entities
- AngioDynamics, Inc. (company) — Registrant
- July 15, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Latham, New York (location) — Address of Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on AngioDynamics, Inc.'s Results of Operations and Financial Condition, Regulation FD Disclosure, and Financial Statements and Exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on July 15, 2025.
In which state is AngioDynamics, Inc. incorporated?
AngioDynamics, Inc. is incorporated in Delaware.
What is the principal executive office address for AngioDynamics, Inc.?
The principal executive office address for AngioDynamics, Inc. is 14 Plaza Drive, Latham, New York 12110.
What is the telephone number for AngioDynamics, Inc.?
The telephone number for AngioDynamics, Inc. is (518) 795-1400.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 15, 2025 regarding ANGIODYNAMICS INC (ANGO).